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Abstract
A 32-year-old gravida 2, para 1 woman without structural cardiac disease was scheduled for her second cesarean
section under combined spinal and epidural anesthesia (CSEA). She had stable hemodynamics after delivery;
however, 16 min after the application of uterotonics, ventricular tachycardia (VT) with a heart rate (HR) of 150 bpm
appeared. VT lasted for <30 s, and her hemodynamics remained stable. Ventricular arrhythmia frequently appeared
for 3 min, and the HR at sinus rhythm was approximately 90 bpm. After the discontinuation of oxytocin, VT did not
reappear. A postoperative 12-lead electrocardiogram showed first-degree atrioventricular block, but echocardiography
performed 2 days later did not reveal any structural abnormalities. Autonomic nervous imbalance induced by CSEA,
ephedrine, and oxytocin, as well as ergometrine may cause intraoperative VT during cesarean section in patients
without structural cardiac disease.
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Background
Ventricular tachycardia (VT) is often observed during
anesthesia. Arrhythmias lasting >30 s (sustained VT)
may cause unstable hemodynamics and require treat-
ment. Although there are some reports documenting
the presence of VT during cesarean section, in most
of these cases, VT was caused by the patients’ cardiac
disease [1–3]. We report the case of non-sustained
VT without structural cardiac disease under combined
spinal and epidural anesthesia (CSEA) during cesarean
section.
Case presentation
A 32-year-old gravida 2, para 1 woman, weighing 56 kg,
was scheduled for a repeat cesarean section which was
indicated because of a previous cesarean section 3 years
back. The previous cesarean section was performed
under intrathecal anesthesia with hyperbaric bupiva-
caine. Oxytocin (5 units) and methylergometrine maleate
(0.2 mg) were administered intravenously as uterotonics
after the birth. Anesthetic complications were not
observed. She had also undergone resection of an ovar-
ian cyst at 16 weeks of gestation under CSEA using
hyperbaric bupivacaine and ropivacaine. Anesthetic
complications were not observed, and the progress of
pregnancy was uneventful. A preoperative examination
conducted before the second cesarean section revealed
no signs or symptoms of cardiovascular disease, and she
was classified as American Society of Anesthesiologists
(ASA) physical status class 1.
After an epidural catheter was inserted at the L2-3
level, hyperbaric bupivacaine (11 mg) was intrathecally
administered at the L3-4 level. Eight minutes after the
start of spinal anesthesia, ephedrine (8 mg) was intraven-
ously injected because the blood pressure (BP) fell to 85/
30 mmHg (Fig. 1). Her hemodynamics recovered imme-
diately, and 10 min after the start of spinal anesthesia,
epidural anesthesia (0.2 % ropivacaine 5 ml/h) was initi-
ated. Seventeen minutes after the start of anesthesia, the
child was delivered. After the birth, oxytocin (5 units)
was mixed in a crystalloid solution (500 ml) and deliv-
ered intravenously over 30 min along with methylergo-
metrine maleate (0.2 mg) injected over 10 min (Fig. 1).
Sixteen minutes after the start of oxytocin and methyler-
gometrine maleate, VT appeared. She complained of
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palpitations but was fully conscious. The longest period
of ventricular rhythm lasted for 49 beats, and the heart
rate (HR) was 150 bpm. Ventricular arrhythmia fre-
quently appeared for 3 min (Fig. 2). BP during the
arrhythmia was approximately 110/50 mmHg, and the
HR at sinus rhythm was 90 bpm. Pulse oximetry showed
oxygen saturation (SpO2) of 98 %. The anesthetic level
was at the T4 dermatome. The injection of methylergo-
metrine had been completed, but the intravenous
oxytocin infusion was still ongoing. After the appearance
of arrhythmia, the oxytocin infusion was stopped imme-
diately and the arrhythmia disappeared. The total dose
of oxytocin infused was 2.5 units. Temporary transcuta-
neous pacing pads combined with a defibrillator were
prepared. However, she was fully conscious and needed
to be sedated for their application. Before sedation was
administered, the arrhythmia disappeared and the defib-
rillator and temporary pacing pads were not used. Anti-
Fig. 1 The anesthetic chart.
Fig. 2 Intraoperative ventricular tachycardia (VT) appeared 16 min after the start of uterotonics in II-lead ECG. The longest VT lasted for 49 beats,
and the heart rate (HR) was 150 bpm. Ventricular arrhythmia frequently appeared for 3 min
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arrhythmic agents were not administered either, because
ventricular arrhythmia did not reappear. Anesthetic dur-
ation was 1 h 3 min, and blood loss was 736 ml includ-
ing amniotic fluid.
Ninety minutes after the appearance of VT, a 12-lead
electrocardiogram (ECG) showed sinus rhythm at a rate
of 60 bpm, a PR duration of 0.215 s, and no ST changes.
In comparison with the preoperative PR duration, the
postoperative PR duration was longer, suggesting first-
degree atrioventricular (AV) block. Methylergometrine
maleate (0.4 mg) was administered intravenously for
10 h after the surgery. During the following 24-h
period, continuous ECG monitoring did not reveal any
ventricular rhythm. A blood test performed 18 h later
revealed normal electrolyte concentrations. Echocardi-
ography performed 2 days later showed no structural
cardiac abnormalities. The patient was discharged on
postoperative day 8 without complications.
Discussion
VT needs to be distinguished from supraventricular tachy-
cardia (SVT) with aberrant conduction or bundle branch
block. VT lacks the preceding P wave at the start of wide
QRS waves, and atrioventricular dissociation is a differen-
tiation point of VT from SVT. In this case, wide QRS
waves with no preceding P waves and atrioventricular dis-
sociation strongly suggested that the arrhythmia was VT
(Fig. 3). VT observed in this case lasted for <30 s. Because
of the short duration and the stable hemodynamics, the
patient did not require any additional treatment.
Ergometrine is broadly used in coronary angiography
and echocardiography for the ergonovine testing of cor-
onary vasospasm [4, 5]. It may cause AV block and VT
along with coronary vasospasm as a consequence of the
ischemic impulse conduction system. In this case, ST
changes were not observed. Postoperative infusion of
ergometrine did not induce ventricular arrhythmia or
ST changes. The rapid intraoperative infusion of ergo-
metrine may have caused ventricular arrhythmia; how-
ever, the relationship between the coronary vasospasm
and the arrhythmia in this case is unclear.
Oxytocin is also related to hemodynamics. Oxytocin-
induced QTc prolongation is an indirect mechanism;
however, oxytocin is known to affect the autonomic ner-
vous nerve tone and the duration of cardiomyocyte repo-
larization and may induce arrhythmias [6]. In this case,
the postoperative ECG revealed normal QTc duration,
which contradicted the expected finding of oxytocin-
induced prolongation.
Ephedrine is a sympathomimetic that has both direct
(alpha and beta receptor agonist) and indirect (release of
norepinephrine from presynaptic nerve terminals) mech-
anisms of action. It has a slow onset of action making it
difficult to titrate the dose [7, 8]. The duration of action
Fig. 3 Wide QRS waves with no preceding P waves and atrioventricular dissociation strongly suggested that the arrhythmia was VT. Green triangle: The
start of wide QRS waves lacked the preceding P wave. The sinus P waves thought to be hidden by wide QRS waves are shown by the green arrow as
well. Black arrow: Sinus P waves. The fourth P wave (orange arrow) was not judged to be connected with the following wide QRS wave, suggesting
atrioventricular dissociation. The fourth P wave (blue arrow) was not judged to be connected with the following wide QRS wave, because of its shorter
PQ duration than usual. Atrioventricular dissociation was suspected
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is approximately 60 min [8]. There is a case report of
VT during general anesthesia, which is thought to have
been caused by autonomic nervous imbalance because
of a combination of ephedrine administration, insuffi-
cient anesthetic depth, neostigmine, and epidural block
[9]. In this case, VT appeared 25 min after the adminis-
tration of ephedrine. Ephedrine administration and
arrhythmia could be related.
CSEA was performed in this case, but the total dose of
local anesthetics was low, and local anesthetic-related
toxicity was ruled out.
Oxytocin and ergometrine were administered during
the previous cesarean section without complications.
Using Naranjo’s adverse drug reaction probability scale
[10], we obtained scores of 2 for ergometrine and 4 for
oxytocin, which make them possible causes for the
event. Autonomic nervous imbalance induced by CSEA,
ephedrine, and oxytocin, as well as ergometrine, a vaso-
constrictor, may have caused the arrhythmia in this case.
Conclusions
Autonomic nervous imbalance induced by the combin-
ation of CSEA, ephedrine, and oxytocin, as well as ergo-
metrine may cause VT in a patient without structural
cardiac disease.
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